Literature DB >> 12660422

Toll-like receptors and their function in innate and adaptive immunity.

Holger Heine1, Egil Lien.   

Abstract

Over the past 3 years our knowledge about how we sense the microbial world has been fundamentally changed. It has been known for decades that microbial products, such as lipopolysaccharide, lipoproteins, or peptidoglycan, have a profound activity on human cells. Whereas the structure of many different pathogenic microbial compounds has been extensively studied and characterized, the molecular basis of their recognition by the cells of the innate immune system remained elusive for a long time. It was Charles Janeway [Cold Spring Harb Symp Quant Biol 1989;54/1:1-13] who developed the idea of microbial structures forming pathogen-associated molecular patterns that would be recognized by pattern recognition receptors. The discovery of the family of Toll receptors in species as diverse as DROSOPHILA and humans, and the recognition of their role in distinguishing molecular patterns that are common to microorganisms have led to a renewed appreciation of the innate immune system. Moreover, it is now clear that the activation of the innate immune system through mammalian Toll-like receptors has also an instructive role for the responses of the adaptive immune response and, thus, may influence allergic diseases such as asthma. Copyright 2003 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12660422     DOI: 10.1159/000069517

Source DB:  PubMed          Journal:  Int Arch Allergy Immunol        ISSN: 1018-2438            Impact factor:   2.749


  31 in total

1.  Flagellin fusion proteins as adjuvants or vaccines induce specific immune responses.

Authors:  Camilo Cuadros; Francisco J Lopez-Hernandez; Ana Lucia Dominguez; Michael McClelland; Joseph Lustgarten
Journal:  Infect Immun       Date:  2004-05       Impact factor: 3.441

2.  A distinct Toll-like receptor repertoire in human tonsillar B cells, directly activated by PamCSK, R-837 and CpG-2006 stimulation.

Authors:  Anne Månsson; Mikael Adner; Ulf Höckerfelt; Lars-Olaf Cardell
Journal:  Immunology       Date:  2006-06-16       Impact factor: 7.397

Review 3.  Liposome-nucleic acid immunotherapeutics.

Authors:  Steven Dow
Journal:  Expert Opin Drug Deliv       Date:  2008-01       Impact factor: 6.648

Review 4.  Immunological control of fish diseases.

Authors:  Bergljot Magnadottir
Journal:  Mar Biotechnol (NY)       Date:  2010-03-30       Impact factor: 3.619

Review 5.  Mucosal immunology and probiotics.

Authors:  Maria Luisa Dongarrà; Valeria Rizzello; Letizia Muccio; Walter Fries; Antonio Cascio; Irene Bonaccorsi; Guido Ferlazzo
Journal:  Curr Allergy Asthma Rep       Date:  2013-02       Impact factor: 4.806

6.  Expression of genes encoding innate host defense molecules in normal human monocytes in response to Candida albicans.

Authors:  Hee Sup Kim; Eun Hwa Choi; Javed Khan; Emmanuel Roilides; Andrea Francesconi; Miki Kasai; Tin Sein; Robert L Schaufele; Kenichi Sakurai; Chang Gue Son; Braden T Greer; Stephen Chanock; Caron A Lyman; Thomas J Walsh
Journal:  Infect Immun       Date:  2005-06       Impact factor: 3.441

7.  Scavenger receptor A is expressed by macrophages in response to Porphyromonas gingivalis, and participates in TNF-alpha expression.

Authors:  M T Baer; N Huang; F C Gibson
Journal:  Oral Microbiol Immunol       Date:  2009-12

8.  Significant correlation of TLR4 expression with the clinicopathological features of invasive ductal carcinoma of the breast.

Authors:  Naureen Ehsan; Sheeba Murad; Tamour Ashiq; Muhammad Uzair Mansoor; Summer Gul; Samra Khalid; Muhammad Younas
Journal:  Tumour Biol       Date:  2013-01-22

9.  NOD2/CARD15 and the Paneth cell: another piece in the genetic jigsaw of inflammatory bowel disease.

Authors:  M C Aldhous; E R Nimmo; J Satsangi
Journal:  Gut       Date:  2003-11       Impact factor: 23.059

10.  FLICE-like inhibitory protein (FLIP) protects against apoptosis and suppresses NF-kappaB activation induced by bacterial lipopolysaccharide.

Authors:  Douglas D Bannerman; Kristine T Eiting; Robert K Winn; John M Harlan
Journal:  Am J Pathol       Date:  2004-10       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.